In contrast to our initial hypothesis, we show that breast cancer patients benefit from postoperative RT regarding IBTR, and any recurrence, also when the primary tumour was HIF-1α IHC positive or had high expression of hypoxic gene signatures. The gene discussed is HIF1A; the disease is breast carcinoma.